Cetera Investment Advisers’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.83M | Sell |
66,785
-12,094
| -15% | -$1.06M | 0.01% | 1092 |
|
|
2025
Q1 | $5.39M | Buy |
78,879
+6,697
| +9% | +$457K | 0.01% | 1060 |
|
|
2024
Q4 | $5.61M | Buy |
72,182
+10,385
| +17% | +$808K | 0.01% | 975 |
|
|
2024
Q3 | $4.14M | Sell |
61,797
-34,354
| -36% | -$2.3M | 0.01% | 1109 |
|
|
2024
Q2 | $10.9M | Sell |
96,151
-10,730
| -10% | -$1.22M | 0.03% | 641 |
|
|
2024
Q1 | $14.8M | Buy |
106,881
+46,297
| +76% | +$6.42M | 0.04% | 504 |
|
|
2023
Q4 | $7.52M | Buy |
60,584
+6,310
| +12% | +$783K | 0.06% | 307 |
|
|
2023
Q3 | $5.06M | Buy |
54,274
+7,910
| +17% | +$738K | 0.04% | 410 |
|
|
2023
Q2 | $5.96M | Sell |
46,364
-224
| -0.5% | -$28.8K | 0.05% | 351 |
|
|
2023
Q1 | $5.41M | Sell |
46,588
-49
| -0.1% | -$5.69K | 0.05% | 371 |
|
|
2022
Q4 | $5.28M | Buy |
46,637
+17,300
| +59% | +$1.96M | 0.05% | 370 |
|
|
2022
Q3 | $2.36M | Sell |
29,337
-2,957
| -9% | -$238K | 0.05% | 407 |
|
|
2022
Q2 | $2.41M | Buy |
32,294
+50
| +0.2% | +$3.73K | 0.04% | 466 |
|
|
2022
Q1 | $4.12M | Buy |
32,244
+1,568
| +5% | +$201K | 0.06% | 329 |
|
|
2021
Q4 | $4.12M | Buy |
30,676
+1,792
| +6% | +$241K | 0.06% | 334 |
|
|
2021
Q3 | $3.95M | Buy |
28,884
+592
| +2% | +$80.9K | 0.06% | 320 |
|
|
2021
Q2 | $3.02M | Buy |
28,292
+16,188
| +134% | +$1.73M | 0.05% | 398 |
|
|
2021
Q1 | $1.09M | Sell |
12,104
-9,584
| -44% | -$861K | 0.02% | 634 |
|
|
2020
Q4 | $2.01M | Buy |
+21,688
| New | +$2.01M | 0.04% | 425 |
|